Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005741 | mitochondrial outer membrane | 5 | 1 |
GO:0005886 | plasma membrane | 3 | 1 |
GO:0016020 | membrane | 2 | 1 |
GO:0019867 | outer membrane | 3 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
GO:0031966 | mitochondrial membrane | 4 | 1 |
GO:0031968 | organelle outer membrane | 4 | 1 |
GO:0098588 | bounding membrane of organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AX62
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0006066 | alcohol metabolic process | 3 | 1 |
GO:0006576 | biogenic amine metabolic process | 5 | 1 |
GO:0006580 | ethanolamine metabolic process | 5 | 1 |
GO:0006644 | phospholipid metabolic process | 4 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0009308 | amine metabolic process | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019637 | organophosphate metabolic process | 3 | 1 |
GO:0034308 | primary alcohol metabolic process | 4 | 1 |
GO:0042439 | ethanolamine-containing compound metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0070291 | N-acylethanolamine metabolic process | 5 | 1 |
GO:1901160 | primary amino compound metabolic process | 4 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:1901615 | organic hydroxy compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0008081 | phosphoric diester hydrolase activity | 5 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 12 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 12 |
GO:0008889 | glycerophosphodiester phosphodiesterase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.333 |
CLV_NRD_NRD_1 | 186 | 188 | PF00675 | 0.406 |
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.336 |
CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.372 |
CLV_NRD_NRD_1 | 99 | 101 | PF00675 | 0.363 |
CLV_PCSK_KEX2_1 | 149 | 151 | PF00082 | 0.294 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.224 |
CLV_PCSK_KEX2_1 | 191 | 193 | PF00082 | 0.412 |
CLV_PCSK_KEX2_1 | 259 | 261 | PF00082 | 0.354 |
CLV_PCSK_KEX2_1 | 327 | 329 | PF00082 | 0.442 |
CLV_PCSK_KEX2_1 | 99 | 101 | PF00082 | 0.279 |
CLV_PCSK_PC1ET2_1 | 149 | 151 | PF00082 | 0.392 |
CLV_PCSK_PC1ET2_1 | 191 | 193 | PF00082 | 0.400 |
CLV_PCSK_PC1ET2_1 | 327 | 329 | PF00082 | 0.481 |
CLV_PCSK_PC7_1 | 187 | 193 | PF00082 | 0.319 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 261 | 265 | PF00082 | 0.466 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.432 |
DEG_SCF_FBW7_1 | 46 | 53 | PF00400 | 0.390 |
DOC_CKS1_1 | 279 | 284 | PF01111 | 0.516 |
DOC_MAPK_gen_1 | 187 | 195 | PF00069 | 0.271 |
DOC_MAPK_gen_1 | 73 | 83 | PF00069 | 0.271 |
DOC_MAPK_gen_1 | 99 | 106 | PF00069 | 0.286 |
DOC_PP1_RVXF_1 | 28 | 34 | PF00149 | 0.319 |
DOC_PP2B_LxvP_1 | 302 | 305 | PF13499 | 0.334 |
DOC_USP7_MATH_1 | 60 | 64 | PF00917 | 0.332 |
DOC_WW_Pin1_4 | 278 | 283 | PF00397 | 0.490 |
DOC_WW_Pin1_4 | 46 | 51 | PF00397 | 0.395 |
LIG_14-3-3_CanoR_1 | 110 | 115 | PF00244 | 0.319 |
LIG_Actin_WH2_2 | 136 | 151 | PF00022 | 0.406 |
LIG_Actin_WH2_2 | 7 | 22 | PF00022 | 0.483 |
LIG_AP2alpha_1 | 83 | 87 | PF02296 | 0.406 |
LIG_APCC_ABBA_1 | 80 | 85 | PF00400 | 0.271 |
LIG_eIF4E_1 | 170 | 176 | PF01652 | 0.390 |
LIG_FHA_1 | 117 | 123 | PF00498 | 0.271 |
LIG_FHA_1 | 153 | 159 | PF00498 | 0.383 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.148 |
LIG_FHA_1 | 262 | 268 | PF00498 | 0.338 |
LIG_FHA_1 | 96 | 102 | PF00498 | 0.262 |
LIG_FHA_2 | 103 | 109 | PF00498 | 0.339 |
LIG_FHA_2 | 124 | 130 | PF00498 | 0.271 |
LIG_LIR_Gen_1 | 206 | 215 | PF02991 | 0.491 |
LIG_LIR_Nem_3 | 160 | 165 | PF02991 | 0.271 |
LIG_LIR_Nem_3 | 206 | 210 | PF02991 | 0.484 |
LIG_LIR_Nem_3 | 293 | 299 | PF02991 | 0.537 |
LIG_MYND_3 | 124 | 128 | PF01753 | 0.262 |
LIG_Pex14_1 | 217 | 221 | PF04695 | 0.347 |
LIG_Pex14_2 | 83 | 87 | PF04695 | 0.406 |
LIG_SH2_NCK_1 | 59 | 63 | PF00017 | 0.153 |
LIG_SH2_STAP1 | 199 | 203 | PF00017 | 0.432 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 18 | 21 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 270 | 273 | PF00017 | 0.438 |
LIG_SH2_STAT5 | 280 | 283 | PF00017 | 0.472 |
LIG_SH3_2 | 25 | 30 | PF14604 | 0.332 |
LIG_SH3_3 | 119 | 125 | PF00018 | 0.390 |
LIG_SH3_3 | 22 | 28 | PF00018 | 0.330 |
LIG_SUMO_SIM_par_1 | 141 | 147 | PF11976 | 0.271 |
LIG_TRAF2_1 | 126 | 129 | PF00917 | 0.294 |
LIG_WRC_WIRS_1 | 175 | 180 | PF05994 | 0.330 |
LIG_WW_1 | 305 | 308 | PF00397 | 0.594 |
MOD_CDK_SPxxK_3 | 278 | 285 | PF00069 | 0.490 |
MOD_CK1_1 | 177 | 183 | PF00069 | 0.409 |
MOD_CK2_1 | 102 | 108 | PF00069 | 0.330 |
MOD_CK2_1 | 123 | 129 | PF00069 | 0.286 |
MOD_GlcNHglycan | 179 | 182 | PF01048 | 0.386 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.332 |
MOD_GSK3_1 | 112 | 119 | PF00069 | 0.312 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.319 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.346 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.390 |
MOD_N-GLC_2 | 266 | 268 | PF02516 | 0.447 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.406 |
MOD_NEK2_1 | 148 | 153 | PF00069 | 0.319 |
MOD_NEK2_1 | 203 | 208 | PF00069 | 0.471 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.299 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.373 |
MOD_PKA_2 | 72 | 78 | PF00069 | 0.271 |
MOD_PKB_1 | 259 | 267 | PF00069 | 0.468 |
MOD_Plk_1 | 102 | 108 | PF00069 | 0.294 |
MOD_Plk_1 | 170 | 176 | PF00069 | 0.271 |
MOD_Plk_1 | 50 | 56 | PF00069 | 0.271 |
MOD_Plk_2-3 | 102 | 108 | PF00069 | 0.330 |
MOD_Plk_4 | 102 | 108 | PF00069 | 0.306 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.272 |
MOD_Plk_4 | 242 | 248 | PF00069 | 0.300 |
MOD_ProDKin_1 | 278 | 284 | PF00069 | 0.483 |
MOD_ProDKin_1 | 46 | 52 | PF00069 | 0.395 |
MOD_SUMO_rev_2 | 144 | 151 | PF00179 | 0.406 |
TRG_DiLeu_BaLyEn_6 | 27 | 32 | PF01217 | 0.447 |
TRG_ENDOCYTIC_2 | 296 | 299 | PF00928 | 0.578 |
TRG_ENDOCYTIC_2 | 308 | 311 | PF00928 | 0.520 |
TRG_ER_diArg_1 | 162 | 164 | PF00400 | 0.339 |
TRG_ER_diArg_1 | 259 | 261 | PF00400 | 0.358 |
TRG_ER_diArg_1 | 326 | 329 | PF00400 | 0.430 |
TRG_ER_diArg_1 | 99 | 101 | PF00400 | 0.362 |
TRG_NLS_MonoExtC_3 | 325 | 330 | PF00514 | 0.392 |
TRG_NLS_MonoExtN_4 | 326 | 331 | PF00514 | 0.341 |
TRG_Pf-PMV_PEXEL_1 | 140 | 144 | PF00026 | 0.271 |
TRG_Pf-PMV_PEXEL_1 | 316 | 321 | PF00026 | 0.597 |
TRG_Pf-PMV_PEXEL_1 | 99 | 103 | PF00026 | 0.363 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3S0 | Leptomonas seymouri | 72% | 100% |
A0A0S4KJA2 | Bodo saltans | 50% | 100% |
A0A1X0NVZ2 | Trypanosomatidae | 54% | 99% |
A0A3Q8IGB4 | Leishmania donovani | 94% | 100% |
A0A422NWY6 | Trypanosoma rangeli | 54% | 99% |
A4HDS7 | Leishmania braziliensis | 79% | 100% |
A4I125 | Leishmania infantum | 94% | 100% |
C9ZW84 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
Q3T0T0 | Bos taurus | 28% | 100% |
Q4QAB4 | Leishmania major | 92% | 100% |
Q9NZC3 | Homo sapiens | 26% | 100% |
V5B577 | Trypanosoma cruzi | 55% | 96% |